Azacitidine/VenetoclaxLack of efficacy and off-label therapy in unapproved indication

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2023年 / 1986卷 / 1期

关键词：

D O I：

10.1007/s40278-023-51388-1

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：83 / 83

相关论文

共 50 条

[1] Azacitidine/decitabine/venetoclaxLack of efficacy and off-label use: 11 case reports
[J]. Reactions Weekly, 2023, 1960 (1) : 84 - 84
[2] Abatacept/cyclophosphamideLack of efficacy and off-label use in unapproved indication
[J]. Reactions Weekly, 2024, 2006 (1) : 13 - 13
[3] Azithromycin/hydroxychloroquine/steroidsLack of efficacy and off-label use in an unapproved indication
[J]. Reactions Weekly, 2024, 2014 (1) : 104 - 104
[4] MethylprednisoloneLack of efficacy and off-label use in unapproved indication: case report
[J]. Reactions Weekly, 2024, 2021 (1) : 303 - 303
[5] Baricitinib/dexamethasone/remdesivirLack of efficacy and off-label use in unapproved indication
[J]. Reactions Weekly, 2024, 1999 (1) : 81 - 81
[6] Antipsoriatics/dupilumabLack of efficacy and off-label use in unapproved indication: case report
[J]. Reactions Weekly, 2023, 1961 (1) : 66 - 66
[7] Anti-inflammatoriesLack of efficacy, off-label use in unapproved indication and drug ineffective for unapproved indication: 5 case reports
[J]. Reactions Weekly, 2023, 1960 (1) : 36 - 36
[8] Multiple drugsLack of efficacy and off-label use (in unapproved indication): 4 case reports
[J]. Reactions Weekly, 2023, 1966 (1) : 245 - 245
[9] DexamfetamineRebound effect in the form of headaches following off-label therapy (in unapproved indication) with dexamfetamine
[J]. Reactions Weekly, 2024, 2004 (1) : 171 - 171
[10] Clopidogrel/quinineDrug-induced thrombotic microangiopathy and off-label therapy in unapproved indication
[J]. Reactions Weekly, 2024, 2003 (1) : 273 - 273

← 1 2 3 4 5 →